135 related articles for article (PubMed ID: 2060518)
1. Antistaphylococcal activity of the fluoroquinolones CI-960, PD 131628, sparfloxacin, ofloxacin and ciprofloxacin.
Barry AL; Fuchs PC
Eur J Clin Microbiol Infect Dis; 1991 Mar; 10(3):168-71. PubMed ID: 2060518
[TBL] [Abstract][Full Text] [Related]
2. Antistaphylococcal activities of sparfloxacin (CI-978; AT-4140), ofloxacin, and ciprofloxacin.
Chaudhry AZ; Knapp CC; Sierra-Madero J; Washington JA
Antimicrob Agents Chemother; 1990 Sep; 34(9):1843-5. PubMed ID: 2285304
[TBL] [Abstract][Full Text] [Related]
3. Anti-staphylococcal activity of temafloxacin, ciprofloxacin, ofloxacin and enoxacin.
Barry AL; Fuchs PC
J Antimicrob Chemother; 1991 Nov; 28(5):695-9. PubMed ID: 1663929
[TBL] [Abstract][Full Text] [Related]
4. Activity of new quinolones against ciprofloxacin-resistant staphylococci.
Forstall GJ; Knapp CC; Washington JA
Antimicrob Agents Chemother; 1991 Aug; 35(8):1679-81. PubMed ID: 1656873
[TBL] [Abstract][Full Text] [Related]
5. In vitro antibacterial activity of trovafloxacin and five other fluoroquinolones.
Montanari MP; Prenna M; Mingoia M; Ripa S; Varaldo PE
Chemotherapy; 1998; 44(2):85-93. PubMed ID: 9551237
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of sparfloxacin, ciprofloxacin, ofloxacin, and other antibiotics against bloodstream isolates of gram-positive cocci.
Rotstein C; Amsterdam D; Beam TR; Mandell LA; Gorzynski EA
Diagn Microbiol Infect Dis; 1993 Jul; 17(1):85-91. PubMed ID: 8395375
[TBL] [Abstract][Full Text] [Related]
7. Antistaphylococcal and antistreptococcal killing kinetics of ciprofloxacin, ofloxacin, sparfloxacin, and trovafloxacin.
Prenna M; Montanari MP; Mingoia M; Biavasco F; Ripa S; Varaldo PE
Eur J Clin Microbiol Infect Dis; 1998 Nov; 17(11):816-9. PubMed ID: 9923533
[No Abstract] [Full Text] [Related]
8. In vitro activity of sparfloxacin and three other fluoroquinolones against methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
Smith KR; Cobbs CG
Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):55-8. PubMed ID: 1314175
[TBL] [Abstract][Full Text] [Related]
9. Comparative activities of clinafloxacin, grepafloxacin, levofloxacin, moxifloxacin, ofloxacin, sparfloxacin, and trovafloxacin and nonquinolones linozelid, quinupristin-dalfopristin, gentamicin, and vancomycin against clinical isolates of ciprofloxacin-resistant and -susceptible Staphylococcus aureus strains.
Jones ME; Visser MR; Klootwijk M; Heisig P; Verhoef J; Schmitz FJ
Antimicrob Agents Chemother; 1999 Feb; 43(2):421-3. PubMed ID: 9925551
[TBL] [Abstract][Full Text] [Related]
10. Activity of nadifloxacin against methicillin-resistant Staphylococcus aureus isolated from skin infections: comparative study with seven other fluoroquinolones.
Nishijima S; Nakagawa M; Tsuboi N; Akamatsu H; Horio T; Fujita M; Kawabata S
J Int Med Res; 1996; 24(1):12-6. PubMed ID: 8674789
[TBL] [Abstract][Full Text] [Related]
11. In-vitro activity of three fluoroquinolones, cefotaxime and clindamycin against staphylococci.
Schumacher-Perdreau F; Peters G
Zentralbl Bakteriol; 1995 Oct; 282(4):389-93. PubMed ID: 9810661
[TBL] [Abstract][Full Text] [Related]
12. The bactericidal activity of levofloxacin against ampicillin-resistant and ampicillin-susceptible Haemophilus influenzae in comparison with ofloxacin, ciprofloxacin and sparfloxacin.
Dabernat H
Int J Antimicrob Agents; 1999 Feb; 11(2):139-43. PubMed ID: 10221417
[TBL] [Abstract][Full Text] [Related]
13. Susceptibilities of penicillin-susceptible and -resistant strains of Streptococcus pneumoniae to RP 59500, vancomycin, erythromycin, PD 131628, sparfloxacin, temafloxacin, win 57273, ofloxacin, and ciprofloxacin.
Spangler SK; Jacobs MR; Appelbaum PC
Antimicrob Agents Chemother; 1992 Apr; 36(4):856-9. PubMed ID: 1323956
[TBL] [Abstract][Full Text] [Related]
14. [In vitro activity of sparfloxacin against methicillin-resistant staphylococci].
Wallrauch C; Voss A; Milatovic D; Braveny I
Arzneimittelforschung; 1995 Jun; 45(6):723-5. PubMed ID: 7646580
[TBL] [Abstract][Full Text] [Related]
15. Comparative activity of ciprofloxacin, ofloxacin, sparfloxacin, temafloxacin, CI-960, CI-990, and WIN 57273 against anaerobic bacteria.
Goldstein EJ; Citron DM
Antimicrob Agents Chemother; 1992 May; 36(5):1158-62. PubMed ID: 1324640
[TBL] [Abstract][Full Text] [Related]
16. Fluoroquinolone resistance among methicillin-resistant staphylococci after usage of fluoroquinolones other than ciprofloxacin in Taiwan.
Chang SC; Hsieh WC; Luh KT
Diagn Microbiol Infect Dis; 1994 Jul; 19(3):143-7. PubMed ID: 7820993
[TBL] [Abstract][Full Text] [Related]
17. Cross-resistance analysis for clinafloxacin compared with ciprofloxacin, fleroxacin, ofloxacin, and sparfloxacin using a predictor panel of ciprofloxacin-resistant bacteria.
Cormican MG; Jones RN
J Antimicrob Chemother; 1995 Aug; 36(2):431-4. PubMed ID: 8522474
[TBL] [Abstract][Full Text] [Related]
18. In-vitro bacteriostatic activity of levofloxacin and three other fluoroquinolones against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Frémaux A; Sissia G; Geslin P
J Antimicrob Chemother; 1999 Jun; 43 Suppl C():9-14. PubMed ID: 10404331
[TBL] [Abstract][Full Text] [Related]
19. In vitro susceptibility of recent gram-positive isolates to ciprofloxacin, levofloxacin, and trovafloxacin.
Isenberg HD; Alperstein P; France K
Diagn Microbiol Infect Dis; 1998 Oct; 32(2):115-8. PubMed ID: 9823535
[TBL] [Abstract][Full Text] [Related]
20. Comparative in vitro activities of ciprofloxacin, gemifloxacin, grepafloxacin, moxifloxacin, ofloxacin, sparfloxacin, trovafloxacin, and other antimicrobial agents against bloodstream isolates of gram-positive cocci.
Hardy D; Amsterdam D; Mandell LA; Rotstein C
Antimicrob Agents Chemother; 2000 Mar; 44(3):802-5. PubMed ID: 10681365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
